Group by Gene: CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy BCL Inhibitors Chemotherapy DNA EGFR Tyrosine Kinase Inhibitors | pembrolizumab | PD1 inhibitor nivolumab | toripalimab-tpzi | Tubulin polymerization promoter, Bcl2 inhibitor carboplatin + paclitaxel | Tubulin polymerization promoter, DNA synthesis inhibitor cisplatin + carboplatin | DCF | TPF | Chemotherapy FOLFOX | FOLFCIS | mFOLFOX6 | MIXE | Immunotherapy, EGFR inhibitor EGFR inhibitor + Immunotherapy | DNA synthesis inhibitor, Thymidylate synthase inhibitor cisplatin + 5-fluorouracil | cisplatin + 5-fluorouracil + capecitabine | Microtubule stabilizer, Tubulin polymerization promoter, DNA synthesis inhibitor cisplatin + docetaxel | Thymidylate synthase inhibitor 5-fluorouracil | capecitabine |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No biomarker | |||||||||||||||||
PD-L1 expression | |||||||||||||||||
MSI-H/dMMR | |||||||||||||||||
PD-L1 overexpression + TMB-H | |||||||||||||||||
CD163 expression | |||||||||||||||||
CD4 expression | |||||||||||||||||
PD-L1 amplification + PD-L2 amplification + TMB-H |